Jump Financial, LLC Biocryst Pharmaceuticals Inc Transaction History

Jump Financial, LLC

$4.3 Billion
Q4 2024

A detailed history of Jump Financial, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 263,338 shares of BCRX stock, worth $2.47 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

263,338

Previous 271,739 3.09%

Holding current value

$2.47 Million

Previous $2.07 Million 4.12%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$7.03 - $8.43 $59,059 - $70,820	-8,401 Reduced 3.09%	263,338 $1.98 Million
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $458,564 - $621,673	71,539 Added 35.73%	271,739 $2.07 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $826,826 - $1.36 Million	200,200 New	200,200 $1.24 Million
Q4 2023 Oct 21, 2024	SELL	$4.98 - $6.77 $1.38 Million - $1.87 Million	-276,142 Reduced 68.2%	128,771 $771,000
Q4 2023 Feb 07, 2024	SELL	$4.98 - $6.77 $1.38 Million - $1.87 Million	-276,142 Reduced 68.2%	128,771 $771,000
Q3 2023 Oct 21, 2024	BUY	$6.71 - $7.92 $2.14 Million - $2.53 Million	319,037 Added 371.51%	404,913 $2.87 Million
Q3 2023 Nov 07, 2023	BUY	$6.71 - $7.92 $2.14 Million - $2.53 Million	319,037 Added 371.51%	404,913 $2.87 Million
Q2 2023 Oct 21, 2024	SELL	$6.96 - $8.81 $1.58 Million - $2.01 Million	-227,665 Reduced 72.61%	85,876 $604,000
Q2 2023 Aug 07, 2023	SELL	$6.96 - $8.81 $1.58 Million - $2.01 Million	-227,665 Reduced 72.61%	85,876 $604,000
Q1 2023 Oct 21, 2024	BUY	$7.94 - $11.84 $899,927 - $1.34 Million	113,341 Added 56.61%	313,541 $2.61 Million
Q1 2023 May 03, 2023	BUY	$7.94 - $11.84 $2.49 Million - $3.71 Million	313,541 New	313,541 $2.61 Million
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $384,948 - $658,008	-33,300 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$11.18 - $15.46 $372,294 - $514,818	33,300 New	33,300 $461,000
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $181,497 - $329,370	-19,105 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $140,803 - $260,019	19,105 New	19,105 $194,000
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $644,623 - $1.65 Million	-191,283 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.43 - $5.53 $656,100 - $1.06 Million	191,283 New	191,283 $657,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

167M

Call Options Held

728K

Put Options Held

989K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.75B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account

Jump Financial, LLC Biocryst Pharmaceuticals Inc Transaction History